Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of (a) stigma and (b) gender norms on trends in the number of men accessing mental health services.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
NHS England’s Advancing Mental Health Equalities Strategy launched in September 2020, to assess inequalities in access, including those based on gender, and to set out guidance on how services should be taking this into account.
Fundamentally, this strategy aims to ensure that access to the timely, high-quality mental healthcare as described in the NHS Long Term Plan is equitable, by equipping systems with the tools and enablers they need to bridge the gaps between people, such as men, faring worse than others in mental health services.
Middle-aged men are identified in Suicide prevention in England: 5-year cross-sector strategy, as a priority group for action. The strategy acknowledges that stigma can be a barrier to people seeking support, and it encourages local government, the National Health Service, and voluntary sector organisations to work together to encourage the reduction of this stigma.
Asked by: John Hayes (Conservative - South Holland and The Deepings)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking to support unpaid carers in rural areas.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
The Care Act (2014) requires local authorities to deliver a wide range of sustainable, high-quality care and support services, including support for unpaid carers. Local authorities are required to undertake a Carer’s Assessment for any unpaid carer who appears to have a need for support, and to meet their eligible needs on request from the carer.
Through the Accelerating Reform Fund (ARF), we are investing £42.6 million for innovative local projects focused on transforming the care sector. The purpose of the ARF is to support two or more projects in each area, with at least one of those having a particular focus on unpaid carers. More than half of the projects, and at least one in each integrated care system area, are focused on identifying, recognising, and supporting unpaid carers.
Asked by: Baroness Jones of Moulsecoomb (Green Party - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what steps they are taking to ensure that the proposed WHO Pandemic Preparedness Treaty, due to be considered by the 77th World Health Assembly in May, will include provisions to improve indoor air quality.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The United Kingdom welcomes the Pandemic Accord as an opportunity to strengthen global health security. Improving indoor air quality remains an important issue in public health. However, as the Accord aims to establish a high-level framework for pandemic prevention, preparedness and response, we have pursued action on this specific issue in other multilateral settings.
The UK continues to support international improvements to indoor air pollution through its engagement with the World Health Organization (WHO). For example, the UK Health Security Agency (UKHSA) contributed to WHO projects in 2020 and 2022 to assess combined exposure to multiple chemicals in indoor air in schools. UKHSA continues to work with the International Society on Indoor Air Quality and Climate on the development of an open database on international indoor environmental quality guidelines. The database aims to be actively used by researchers, practitioners, and policymakers across the world.
Moreover, the UK was a strong advocate for action to improve indoor air quality at last year’s United Nations General Assembly. We worked with international partners on this issue during the High-Level Meeting on Universal Health Coverage. The UK was supportive of reference being made to the health impacts of indoor air pollution, which was subsequently adopted in the meeting’s political declaration on 5 October 2023, and is available on the United Nations website in an online-only format.
Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what data they are gathering on countries currently implementing immunisation programmes for infant respiratory syncytial virus regarding (1) acceptance and uptake, and (2) hospitalisations.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The UK Health Security Agency continues to monitor international reporting. In the United States, as of 31 January 2024, maternal immunisation was 17.9%. By February 2024, 43% of infants under eight months old had received a dose of nirsevimab.
In Galicia, Spain, 92.9% of 5,357 infants born between 25 September 2023 and 4 February 2024 had nirsevimab, plus 79.7% of 5,823 in a catch-up programme. The peak of hospitalisation rate in infants under six months old was 102 per 100,000, for season 2023 to 2024 during the week starting 27 November 2023 compared to a median of 776 for seasons 2017 to 2018, 2018 to 2019 and 2019 to 2020, peaking during the first week of January 2024.
In Luxembourg, 84% of 1,524 infants born in hospital between early October and mid-December 2023 received nirsevimab. Luxembourg observed a decrease in hospitalisation in infants under six months old of 69% between the 2022 to 2023 and 2023 to 2024 respiratory syncytial virus seasons.
Asked by: Preet Kaur Gill (Labour (Co-op) - Birmingham, Edgbaston)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many NHS Inpatient Detox units there are by location.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
There are eight NHS inpatient detoxification units in England. They are listed below:
Guys and St Thomas NHS Trust (London),
Bridge House, Kent and Medway NHS Trust (Maidstone, Kent),
Dame Carol Black Unit, Midlands Foundation NHS Trust (Fareham, Hampshire),
Acer Unit, Avon & Wiltshire Mental Health Partnership NHS Trust (Bristol),
Edward Myers Unit, Staffordshire Combined NHS Trust (Stoke),
New Beginnings, Rotherham, Doncaster, South Humber Foundation NHS Trust (Doncaster), Chapman Barker Unit, Greater Manchester Mental Health NHS Trust (Manchester),
Topaz Ward, Essex Partnership NHS Trust (Chelmsford, Essex).
Asked by: Yasmin Qureshi (Labour - Bolton South East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will make it her policy to commission an independent review of the Commission on Human Medicines’ Expert Working Group’s report on Hormone Pregnancy Tests.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
We remain hugely sympathetic to the families who believe that they have suffered as a result of using Hormone Pregnancy Tests. We have no plans to set up an independent review to examine the findings of the Expert Working Group. In the interests of transparency, all evidence collected and papers considered by the Expert Working Group were published in 2018, along with full minutes of its discussions. Details of conflicts of interests, and how these were managed, were also published.
Asked by: Helen Grant (Conservative - Maidstone and The Weald)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what progress her Department has made on increasing access to dentists in Maidstone and the Weald constituency.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
In the 24 months to June 2023, 496,306 adults were seen by a National Health Service dentist in Kent and Medway Integrated Care Board (ICB). This figure is 12% higher than the year before, where 444,190 adults were seen by an NHS dentist, in the 24 months to June 2022.
On 7 February 2024, we published Faster, simpler, and fairer: our plan to recover and reform NHS dentistry, which is backed by £200 million and will fund approximately 2.5 million additional appointments. The plan sets out our actions to improve dental access for patients across the country to address the challenges facing NHS dentistry, including in Maidstone and the Weald.
A new patient premium is supporting dentists in taking on new patients, and a new marketing campaign will help everyone who needs an NHS dentist in finding one. We have further supported dentists by raising the minimum Units of Dental Activity rate to £28 this year, making NHS work more attractive and sustainable.
From 1 April 2023, the responsibility for commissioning primary care dentistry to meet the needs of the local population has been delegated to all ICBs across England. Kent and Medway ICB is responsible for having local processes in place to identify areas of need, and determine the priorities for investment across the ICB area.
Asked by: Helen Grant (Conservative - Maidstone and The Weald)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent progress she has made on retaining more GPs.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
There were 2,799 more full time equivalent (FTE) doctors working in general practice (GP) in December 2023, compared to December 2019. The Government is working with NHS England to increase the GP workforce in England. This includes measures to boost recruitment, address the reasons why doctors leave the profession, and encourage them to return to practice. NHS England has made available a number of retention schemes, to boost the GP workforce.
Asked by: Tanmanjeet Singh Dhesi (Labour - Slough)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking with Cabinet colleagues to help ensure that lobbying by the tobacco industry does not undermine future public health policies aimed at reducing smoking rates.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
Smoking is responsible for approximately 80,000 deaths a year in the United Kingdom, and causes around one in four cancer deaths in the UK. It also costs our country £17 billion a year, and puts a huge burden on the National Health Service. Smoking is an addiction, and there is no liberty in addiction. It causes harm to not only the smoker, but to society as a whole. That is why we have introduced the Tobacco and Vapes Bill to create the first smokefree generation, and enable us to further crack down on youth vaping. The Tobacco and Vapes Bill is available at the following link:
https://bills.parliament.uk/bills/3703
The UK is a party to the World Health Organization Framework Convention on Tobacco Control, and under Article 5.3 has an obligation to protect the development of public health policy from the vested interests of the tobacco industry. As a world leader in tobacco control, the Government takes this commitment very seriously. In 2023, the Department published guidance for Government engagement with the tobacco industry, which is available at the following link:
The Department regularly publishes correspondence from, or to, those with links to the tobacco industry, and it is available at the following link:
https://khub.net/web/phe-national/public-library/-/document_library/v2WsRK3ZlEig/view/394794557
Asked by: Baroness Goudie (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what steps they are taking to ensure that the NHS is prepared for the arrival of new diagnostic innovations for dementia.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Health Service is a world leader in rolling out innovative treatments and has established a dedicated national programme team which is working in partnership with other national agencies and with local health systems to prepare for the potential roll out of new treatments for use in the earlier stages of Alzheimer’s disease. These plans assume that, if these new treatments are approved by the regulators, significant additional diagnostic capacity, including amyloid positron emission tomography–computed tomography, lumbar puncture and magnetic resonance imaging, will be needed both to identify patients who are most able to benefit and to provide important safety monitoring.
The national programme team is conducting preparations across the country, working alongside clinicians and local teams to identify where further funding will be required to roll out the additional tests and services needed to introduce these new and complex treatments.
NHS England is also working with partner agencies to support and inform further research into other diagnostic modalities, including blood-based biomarker and digital tests, which will help improve identification and management of Alzheimer’s disease.